Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment [Phase 1, Phase 2]
Clinical trial update for neratinib in children and young adults with cancer, focusing on safety and dose finding in Phase 1/Phase 2.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer [Phase 1, Phase 2]
This clinical trial update reports that REC-1245 is being studied in Phase 1/Phase 2 trials for unresectable, locally advanced, or metastati…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: PET-CT in Lymphoma Among the Eldery
A clinical trial at Assiut University is evaluating PET-CT imaging in elderly patients with lymphoma; the study is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers [Phase 2, Phase 3]
The DETERMINE trial treatment arm 01 is evaluating Alectinib in adult, paediatric and teenage/young adult patients with ALK-positive cancers…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating repotrectinib in pediatric and young adult patients with ALK, ROS1, or NTRK1-3 alterations in locally …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: First in Human, Dose Escalation Study of AN4005 [Phase 1]
First-in-human, dose-escalation study of AN4005 in patients with advanced solid tumors and advanced lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Tumor Molecular Profiling in Early Phase Clinical Trials
The document describes an early-phase clinical trial program using tumor molecular profiling in patients with solid tumors and lymphoma, whi…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue [Phase 2]
This Phase 2 trial evaluates cognitive behavioral therapy to reduce cancer-related fatigue in patients with acute myeloid leukemia and lymph…
-
CLINICAL_TRIALS other · 2025-11-10Clinical Trial Update: Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies
This clinical trial is evaluating neurocognitive outcomes after whole brain radiation therapy in patients with CNS lymphoma and other hemato…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: A Study of N-Acetylcysteine (N-AC) in People Receiving CAR T-cell Therapy for Lymphoma [Phase 1]
Phase 1 clinical trial updating on the use of N-acetylcysteine (N-AC) in patients receiving CAR T-cell therapy for lymphoma.
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M) [Phase 2]
A phase 2 MATCH subprotocol M trial update evaluating MLN0128 (TAK-228) as a targeted treatment for cancers with TSC1 or TSC2 genetic change…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E) [Phase 2]
This update describes a Phase 2 MATCH subprotocol evaluating larotrectinib (LOXO-101) in cancers with NTRK gene alterations; the trial statu…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N) [Phase 2]
Phase 2 MATCH subprotocol update evaluating GSK2636771 for cancers with PTEN genetic changes; results were posted in 2025.
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I) [Phase 2]
Phase 2 MATCH subprotocol Z1I study evaluating AZD1775 (adavosertib) as a targeted treatment for cancers with BRCA genetic changes. The tria…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With mTOR Genetic Changes (MATCH - Subprotocol L) [Phase 2]
Phase 2 MATCH subprotocol L clinical trial evaluating MLN0128 (TAK-228) for cancers with mTOR genetic changes; status is ACTIVE_NOT_RECRUITI…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies [Phase 2]
Phase 2 clinical trial evaluating allogeneic stem cell transplantation with alpha/beta T and B cell depletion for hematologic malignancies; …
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas [NA]
A recruiting study evaluating the feasibility and clinical utility of circulating cell-free DNA to identify actionable alterations and minim…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Living Well With Lymphoma [NA]
This document reports that a lymphoma clinical trial sponsored by the University of Michigan Rogel Cancer Center is currently recruiting.
-
EMA approval · 2025-10-27EMA Authorised: Elzonris (tagraxofusp) — Stemline Therapeutics B.V.
The EMA authorised Elzonris (tagraxofusp) for a lymphoma indication and designated it as an orphan medicine (decision date 17 September 2025…
-
CLINICAL_TRIALS trial_result · 2025-10-27Clinical Trial Update: Resiliency in Older Adults Undergoing Bone Marrow Transplant
A completed clinical trial update from Johns Hopkins on resiliency in older adults undergoing bone marrow transplant for hematologic cancers…
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
This MD Anderson Cancer Center study is developing a video game to improve outcomes for stem cell transplant survivors, with recruitment ong…
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
This ClinicalTrials.gov update describes an ongoing study that collects tissue, blood, and body fluid samples from patients with hematologic…
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: Looking at Cognitive and Brain Changes in People With Lymphoma Receiving CAR-T Therapy
MSK is conducting an ongoing clinical trial to assess cognitive and brain changes in lymphoma patients receiving CAR-T cell therapy. The stu…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Loss of Expression (MATCH-Subprotocol P) [Phase 2]
Phase 2 trial update evaluating GSK2636771 in cancers with PTEN loss under the MATCH program; the study is active but not recruiting and res…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R) [Phase 1]
This update describes an ongoing Phase I clinical trial evaluating PET imaging with the radiotracer [18F] 4-L-Fluoroglutamine in patients wi…